Evidence map›Paper›PMID 27773409›Full record

ArticleIndian heart journal

Role of PET-CT in the assessment of myocardial viability in patients with left ventricular dysfunction.

Madhur Kumar Srivatsava, M Indirani, I Sathyamurthy, G Sengottuvelu, Avani S Jain, S Shelley

Open access · goldAbstract read
In one paragraph

Article in Indian heart journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Application of animal and human PET in cardiac research.American journal of cardiovascular disease · 2018
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Madhur Kumar SrivatsavaConsultant, Nuclear Medicine and PET-CT, Yashoda Hospital, Hyderabad, India.
M IndiraniDepartment of Nuclear Medicine and PET-CT, Apollo Main Hospital, Chennai, India.
I SathyamurthyInterventional Cardiologist, Dept of Cardiology, Apollo Main Hospital, 21, Greams Lane, Chennai 600006, India. Electronic address: drismurthy@gmail.com.
G SengottuveluInterventional Cardiologist, Dept of Cardiology, Apollo Main Hospital, 21, Greams Lane, Chennai 600006, India.
Avani S JainDepartment of Nuclear Medicine and PET-CT, Apollo Main Hospital, Chennai, India.
S ShelleyDepartment of Nuclear Medicine and PET-CT, Apollo Main Hospital, Chennai, India.
Apollo Hospitals · INYashoda Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimRole of PET-CT in assessment of myocardial viability in patients with LV dysfunction.

methodsThis prospective study included 120 patients with LV dysfunction who underwent 99mTechnetium-Sestamibi myocardial perfusion SPECT-CT and 18FFDG cardiac PET-CT. They also underwent serial echocardiography and coronary angiography along with myocardial perfusion and FDG PET study.

resultsThirty-three patients had single vessel disease, 48 had triple vessel disease, and rest had double vessel disease. Among 786 segments, matched defects were seen in 432 (55%) and mismatched defects in 354 (45%) segments. 78 patients were surgically managed, and 42 were medically managed. The change in LVEF after surgical management was statistically significant compared to medical management.

conclusionViability assessment should be performed in patients who present after 12h of acute myocardial infarction or with LV dysfunction due to ischemic heart disease to decide upon appropriate surgical management.

Indexed as

AgedCoronary AngiographyCoronary Artery DiseaseEchocardiographyFemaleHeart VentriclesHumansMaleMiddle AgedPositron Emission Tomography Computed TomographyProspective StudiesRadiopharmaceuticalsReproducibility of ResultsTechnetium Tc 99m SestamibiVentricular Dysfunction, LeftVentricular Function, LeftRadiopharmaceuticalsTechnetium Tc 99m SestamibiF-18 FDG cardiac PET-CTLV dysfunctionMyocardial viability

Identifiers

PMID27773409
PMCPMC5079123
OpenAlexW2240035583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.